首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

2058207

肝素鈉市場：依產品類型、原料、給藥途徑、應用、最終用戶、通路和地區分類。

Heparin Sodium Market, By Product Type, By Source, By Route of Administration, By Application, By End User, By Distribution Channel, By Geography

出版日期: 2026年05月13日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，肝素鈉市場規模將達84.2億美元，到2033年將達到129.6億美元。預計從2026年到2033年，其複合年成長率將達到6.4%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	84.2億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	6.40%	2033年市場規模預測：	129.6億美元

肝素鈉是一種常用的抗凝血劑，用於預防和治療血栓性栓塞症，例如深層靜脈栓塞症、肺動脈栓塞和急性冠狀動脈症候群。該藥物廣泛用於心血管手術、透析、體外循環和其他重症監護環境中，以抑制血液凝固。

心血管疾病、手術和需要血液透析的慢性腎臟病盛行率的不斷上升是全球市場需求的主要促進因素。此外，人口老化和住院率的上升也對醫療機構中抗凝血劑的使用產生了積極影響。

此外，注射劑生產技術的進步和預混合料肝素產品的出現，使抗凝血劑的使用更加便利安全。製藥公司正努力擴大產能、加強供應鏈，以滿足全球市場對抗凝劑日益成長的需求。

此外，由於原料來自動物（主要是豬），生產過程中的品質標準和可追溯性變得日益重要。另外，隨著開發中國家醫療基礎設施投資的增加，以及血栓症預防和術前抗凝血治療知識的不斷提高，預計未來幾年肝素鈉產業將持續成長。

市場動態

由於心血管疾病、靜脈血栓栓塞症、肺動脈栓塞和需要抗凝血治療的慢性腎臟病的盛行率不斷上升，全球肝素鈉市場經歷了顯著成長。肝素鈉因其快速有效的抗凝血作用，仍是外科手術、透析、導管沖洗和體外循環迴路中不可或缺的藥物。住院患者和加護病房患者數量的增加是肝素鈉消費量增加的主要原因。此外，開發中國家醫療基礎設施的改善也可能推動未來市場成長。

然而，在預測期內，多種因素限制了市場成長。出血和肝素誘發的血小板減少性疾病不利事件的風險要求謹慎的劑量管理，這阻礙了門診肝素鈉市場的進一步發展。此外，生產者在肝素鈉生產中對動物性原料（尤其是豬腸黏膜）的嚴重依賴，使市場面臨原料短缺和價格波動等供應鏈風險。此外，日益嚴格的監管以及對藥品生產品質、安全和透明度的更嚴格監督，也給受調查市場的生產商帶來了更大的壓力。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球肝素鈉市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務績效和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球肝素鈉市場報告旨在為行業內的各種相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球肝素鈉市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第11章競爭格局

Pfizer Inc.
Sanofi
Baxter International Inc.
Braun Melsungen AG
Aspen Pharmacare
LEO Pharma A/S
Reddy's Laboratories Ltd.
Fresenius Kabi
Teva Pharmaceutical Industries Ltd.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

第12章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第13章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI9492

Heparin Sodium Market is estimated to be valued at USD 8.42 Bn in 2026 and is expected to reach USD 12.96 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.4% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 8.42 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.40%	2033 Value Projection:	USD 12.96 Bn

Heparin sodium is an anticoagulant drug that is frequently prescribed for preventing and treating thromboembolic conditions such as deep vein thrombosis, pulmonary embolism, and acute coronary syndrome. The medicine is largely applied in the course of heart surgeries, dialysis treatment, extracorporeal circulation, and other critical care applications in order to inhibit blood clotting.

Growing incidence of cardiovascular diseases, surgical procedures, and chronic kidney diseases necessitating hemodialysis therapy have become major drivers sustaining the market demand worldwide. Moreover, the increasing aged population and number of admissions into hospitals also positively influence the use of anticoagulant medications in medical institutions.

In addition, developments in the manufacturing of injectable pharmaceuticals and emergence of premixed heparin products make anticoagulants more convenient and safer for patients. Manufacturers of pharmaceuticals are making efforts to increase their production capacity and enhance supply chains to meet the rising demand for anticoagulant drugs in the global market.

There is also a growing importance attached to quality standards and traceability in the production process as the raw material is sourced from animals (mainly pigs). Furthermore, increased investment in health care infrastructure in developing countries, along with increased knowledge about thrombosis prevention and anticoagulation treatment before surgery, will likely create growth prospects for the heparin sodium industry in the coming years.

Market Dynamics

The global heparin sodium market has witnessed a significant growth due to the increasing prevalence of cardiovascular disorders, venous thromboembolism, pulmonary embolism, and chronic kidney disorders that demand anticoagulants. Heparin sodium has remained essential for use in surgeries, dialysis, catheter flush, and extracorporeal circuits because of its fast anticoagulant action and effectiveness. An increased number of patients admitted in hospitals and critical care units has made a considerable contribution in promoting the consumption of heparin sodium. Furthermore, improved healthcare infrastructure in developing nations will boost the future growth of the market.

Nonetheless, a number of issues may restrict the market growth over the forecast period. The threat of negative outcomes, such as hemorrhage and heparin-induced thrombocytopenia, makes the proper dosage control essential, preventing the further development of heparin sodium market in the outpatient segment. Additionally, the high dependence of the producers on animal sources for the production of heparin sodium, especially porcine intestinal mucosa, exposes the market to supply chain risks, which include the lack of materials and price changes. Moreover, growing regulation and increasing control over the quality, safety, and transparency of drug manufacturing have put additional pressure on manufacturers in the market under analysis.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global heparin sodium market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer Inc., Sanofi, Baxter International Inc., B. Braun Melsungen AG, Aspen Pharmacare, LEO Pharma A/S, Dr. Reddy's Laboratories Ltd., Fresenius Kabi, Teva Pharmaceutical Industries Ltd., and Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global heparin sodium market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global heparin sodium market

Market Segmentation

Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Unfractionated Heparin (UFH)
- Low Molecular Weight Heparin (LMWH)
Source Insights (Revenue, USD Bn, 2021 - 2033)
- Porcine-derived
- Bovine-derived
Route of Administration Insights (Revenue, USD Bn, 2021 - 2033)
- Intravenous
- Subcutaneous
Application Insights (Revenue, USD Bn, 2021 - 2033)
- Venous Thromboembolism (VTE)
- Atrial Fibrillation & Coronary Artery Disease
- Kidney Dialysis
- Surgery & Critical Care
- Others
End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Dialysis Centers
- Specialty Clinics
- Others
Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Pfizer Inc.
- Sanofi
- Baxter International Inc.
- Braun Melsungen AG
- Aspen Pharmacare
- LEO Pharma A/S
- Reddy's Laboratories Ltd.
- Fresenius Kabi
- Teva Pharmaceutical Industries Ltd.
- Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Heparin Sodium Market, By Product Type
- Global Heparin Sodium Market, By Source
- Global Heparin Sodium Market, By Route of Administration
- Global Heparin Sodium Market, By Application
- Global Heparin Sodium Market, By End User
- Global Heparin Sodium Market, By Distribution Channel
- Global Heparin Sodium Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Regulatory Scenario
Key Developments
Industry Trends

4. Global Heparin Sodium Market, By Product Type, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Unfractionated Heparin (UFH)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Low Molecular Weight Heparin (LMWH)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Heparin Sodium Market, By Source, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Porcine-derived
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Bovine-derived
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Heparin Sodium Market, By Route of Administration, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Heparin Sodium Market, By Application, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Venous Thromboembolism (VTE)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Atrial Fibrillation & Coronary Artery Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Kidney Dialysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Surgery & Critical Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

8. Global Heparin Sodium Market, By End User, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Ambulatory Surgical Centers (ASCs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Dialysis Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

9. Global Heparin Sodium Market, By Distribution Channel, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

10. Global Heparin Sodium Market, By Region, 2021 - 2033, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

11. Competitive Landscape

Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Baxter International Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Braun Melsungen AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Aspen Pharmacare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
LEO Pharma A/S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Reddy's Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fresenius Kabi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies